Chapter 4 - Endocrine, nutritional and metabolic diseases (E00-E89)»Metabolic disorders (E70-E88)»Tumor lysis syndrome (E88.3)
E88.3
Tumor lysis syndrome
Related indications (MeSH) (1)
Tumor Lysis Syndrome4 drugs (4 approved)
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.